Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00582_DB00921> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00582_DB00921 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00582_DB00921 label "DDI between Voriconazole and Buprenorphine - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of buprenorphine by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of buprenorphine if voriconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00582_DB00921]" assertion.
- drugbank_resource:DB00582_DB00921 identifier "drugbank_resource:DB00582_DB00921" assertion.
- drugbank_resource:DB00582_DB00921 title "DDI between Voriconazole and Buprenorphine - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of buprenorphine by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of buprenorphine if voriconazole is initiated, discontinued or dose changed." assertion.